Neuropsychopharmacology
- Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine2 years ago
- Are novel treatments for brain disorders hiding in plain sight?2 years ago
- Closing the loop in psychiatric deep brain stimulation: physiology, psychometrics, and plasticity2 years ago
- Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior2 years ago
- Atypical cortical networks in children at high-genetic risk of psychiatric and neurodevelopmental disorders2 years ago
- Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice2 years ago
- Blocking μ-opioid receptors attenuates reinstatement of responding to an alcohol-predictive conditioned stimulus through actions in the ventral hippocampus2 years ago
Journal of Psychopharmacology
- Histamine H3 receptor gene variants associated with drug abuse in patients with cocaine use disorder5 years ago
- Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking5 years ago
- The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence5 years ago
- Paternal exposure to morphine during adolescence potentiates morphine withdrawal in male offspring: Involvement of the lateral paragigantocellularis nucleus5 years ago
- Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention5 years ago
- Acute subjective effects in LSD- and MDMA-assisted psychotherapy5 years ago
- Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans5 years ago
European Neuropsychopharmacology
- Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study5 years ago
- Bipolar disorder cohort studies: Crucial, but underfunded5 years ago
- Anterior cingulate cortex neuro-metabolic changes underlying lithium-induced euthymia in bipolar depression: A longitudinal 1H-MRS study5 years ago
- Editorial5 years ago
- Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise5 years ago
- The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years5 years ago
- Are we ready for precision medicine for Autism? And who wants it?5 years ago